SCHEMBL18758337

SCHEMBL18758337

CCOP(=O)(Cc1csc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)n1)OCC

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GCK P35557 1/20 0.33
KCNH2 Q12809 1/20 0.33
LMNA P02545 1/20 0.32
CFTR P13569 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
MAPT P10636 1/20 0.31
GSTO1 P78417 1/20 0.31
HTT P42858 1/20 0.30
ABCB1 P08183 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20535745 0.85 MEN1 (0.36) MEN1KMT2ALMNAGSTO1
SCHEMBL18758332 0.81 BCHE (0.34) MEN1KMT2AGCKKCNH2SMN1; SMN2
SCHEMBL28370917 0.80 GCK (0.33) GCKKCNH2
SCHEMBL20387999 0.79 MEN1 (0.40) MEN1KMT2ALMNACFTRSMN1; SMN2
SCHEMBL20388000 0.77 MEN1 (0.36) MEN1KMT2ALMNAGSTO1
SCHEMBL18758339 0.76 MEN1 (0.39) MEN1KMT2AKCNH2LMNACFTR
SCHEMBL1133371 0.76 SMN1; SMN2 (0.46) MEN1KMT2AGCKKCNH2LMNA
SCHEMBL2035163 0.74 HDAC1 (0.33) GCKMAPTHTT
SCHEMBL17674555 0.74 MEN1 (0.37) MEN1KMT2ALMNACFTRGSTO1
SCHEMBL17674557 0.73 MEN1 (0.35) MEN1KMT2ALMNAGSTO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110944664-A Aziridines containing epothilone analogs, methods of synthesis, methods of treatment, and drug conjugates 威廉马歇莱思大学 2020-03-31 CN disclosed
WO-2017066606-A1 EPOTHILONE ANALOGS, METHODS OF SYNTHESIS, METHODS OF TREATMENT, AND DRUG CONJUGATES THEREOF WILLIAM MARSH RICE UNIVERSITY (US) 2017-04-20 WO disclosed